Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: Is there a preferred regimen?

被引：24
|
作者：
Einhorn, LH [1 ]
Foster, RS
机构：
[1] Indiana Univ, Dept Med, Indianapolis, IN 46204 USA
[2] Indiana Univ, Dept Urol, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 16期
关键词：
D O I：
10.1200/JCO.2006.05.6184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2597 / 2598
页数：2
相关论文
共 50 条
  • [31] Three cycles of etoposide and cisplatin chemotherapy in clinical stage IS nonseminomatous testicular cancer
    Zaza Mezvrishvili
    Laurent Managadze
    International Urology and Nephrology, 2006, 38 : 621 - 624
  • [32] Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors
    Pautier, P.
    Gutierrez-Bonnaire, M.
    Rey, A.
    Sillet-Bach, I.
    Chevreau, C.
    Kerbrat, P.
    Morice, P.
    Duvillard, P.
    Lhomme, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (03) : 446 - 452
  • [33] COMBINATION CHEMOTHERAPY WITH VINBLASTINE, BLEOMYCIN, CISPLATIN, AND ETOPOSIDE (VBPE) IN CHILDREN WITH PRIMARY INTRACRANIAL GERM-CELL TUMORS
    CHANG, TK
    WONG, TT
    HWANG, B
    MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (06): : 368 - 372
  • [34] TREATMENT OF PERSISTENT OR RELAPSING ADVANCED GERM-CELL NEOPLASMS WITH CISPLATIN, ETOPOSIDE AND BLEOMYCIN
    HANSEN, SW
    DAUGAARD, G
    RORTH, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (05): : 595 - 599
  • [35] Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors - Final analysis of an intergroup trial
    Hinton, S
    Catalano, PJ
    Einhorn, LH
    Nichols, CR
    Crawford, ED
    Vogelzang, N
    Trump, D
    Loehrer, PJ
    CANCER, 2003, 97 (08) : 1869 - 1875
  • [36] Testicular Germ Cell Tumors in Children and Adolescents Treated With Bleomycin, Etoposide, and Cisplatin (BEP) Protocol: A Survival Analysis
    Suarez, Amaranto
    Prada-Avella, Ma. Camila
    Pabon, Eddie
    Buitrago, Jorge L.
    Hernandez, Jorge
    Lopera, Jhon
    Mesa, Mauricio
    Calderon, Alejandra
    Barajas, Luisa
    Munoz, Javier
    Pina, Martha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [37] Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?
    Einhorn, Lawrence H.
    Adra, Nabil
    Hanna, Nasser
    Nichols, Craig
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26)
  • [38] Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)
    Funt, Samuel
    McHugh, Deaglan Joseph
    Tsai, Stephanie
    O'Donnell, Devon
    Knezevic, Andrea
    Patil, Sujata
    Silber, Deborah
    Reuter, Victor E.
    Sheinfeld, Joel
    Carver, Brett Stewart
    Carousso, Maryann
    Motzer, Robert J.
    Bajorin, Dean F.
    Bosl, George J.
    Feldman, Darren R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II)) vinblastine, bleomycin (VBIV) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors
    Culine, S
    Theodore, C
    Bekradda, M
    Farhat, F
    TerrierLacombe, MJ
    Droz, JP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (02): : 184 - 188
  • [40] One cycle of bleomycin, etoposide and cisplatin plus two cycles of etopeside and cisplatin chemotherapy in selected patients with low-volume stage II nonseminomatous germ cell tumour of the testis
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 171 - 171
12345